CV Sciences (CVSI) Other Operating Expenses (2015 - 2021)

CV Sciences (CVSI) posted Other Operating Expenses of $2.4 million for Q4 2017, up 221.39% sequentially from $756714.0 in Q3 2015.

CV Sciences (CVSI) Other Operating Expenses (2015 - 2021) Analysis & Trends

CV Sciences has reported Other Operating Expenses for 2 years, with the latest figure at $2.4 million in Q4 2017.

Quarterly Other Operating Expenses changed N/A year-over-year to $2.4 million in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $2.4 million (changed N/A YoY) and the FY2017 annual result came in at $2.4 million, changed N/A from the prior year.
Other Operating Expenses climbed to $2.4 million in Q4 2017 per CVSI's latest filing, from $756714.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $2.4 million in Q4 2017 and troughed at $756714.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-
2	Teva Pharmaceutical Industries	43.41 Bn	39.75 Bn	2.15 Bn
3	Zoetis	31.83 Bn	30.15 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.97 Bn	5.10 Bn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn
8	Elanco Animal Health	11.93 Bn	11.40 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-
10	CV Sciences	4.10 Mn	3.84 Mn	1.45 Mn

Download Data